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SUMMARY
Background: ThebenefitofThrombolytic Therapy (TT)foracutemyocardialinfarctionistime
sensitive. In Northern Ireland widespread availability of mobile coronary care units facilitates
deliveryofTTtoheartattackvictims. This region-wideprospective observationalstudyassessed
the efficacy ofvarious methods ofdelivery of TT.
Methods: All 15acutehospitalsprovidingacutecoronarycareinNorthernIrelandparticipated
and data were collected prospectively over six months on all patients admitted with acute
myocardial infarction or who received TT. The information was analysed regarding
appropriatenessofTT,methodsandtimelinessofdeliveryofTTandmortalityrates.Performance
was measured against National Service Framework standards.
Findings: Of1638patientswithacutemyocardialinfarction584wereconsideredeligibleforTT
and 494 (85%) received it, in addition to 18 patients without infarction. Ofthe 512 thrombolysed
patients 282 (55%) were treated in hospital coronary care units, 131 (26%) were treated pre-
hospital, 97 (19%) in accident and emergency departments, and two in general medical wards.
Overall median call-to-needle time was 87 (7-1110) mins and this was shortest for pre-hospital
treatment when 55% of call-to-needle times were s 60 mins. For patients treated in hospital
mediandoor-to-needletimewas46(0-1065)minsandthiswasshortestwhenTTwasadministered
by accident and emergency staff, when 65% ofdoor-to-needle times were < 30 mins. In patients
with STelevationmyocardialinfarction TT was associated withlowermortality,especially when
administered pre-hospital.
Interpretation: NSFtargetsforTTareunlikelytobemetinNorthernIrelandwithoutincreasing
pre-hospital delivery ofTT and by improving collaboration between coronary care and accident
and emergency staff with TT availability in accident and emergency departments.
INTRODUCTION
The introduction of thrombolytic therapy (TT)
for acute myocardial infarction in the 1980's
contributedgreatly toimprovementinboth short'-5
and long term 6,7,8 survival rates. Early studies
showed that the benefit achieved was inversely
related to the delay between onset of symptoms
and delivery of the thrombolytic drug." 3 5 9
Throughout Northern Ireland mobile coronary
care became widely available following the
pioneering work of Pantridge and Geddes in
Belfast in 1966 10 and reduction of community
mortality rateformyocardial infarction achieved
by a mobile coronary care unit was clearly
demonstrated inthepre-thrombolytic era."I With
the advent ofTT it appeared that the availability
ofmobileunits shouldfacilitateitsrapiddelivery
to victims of myocardial infarction outside
hospital. The benefit of prompt pre-hospital TT
hasbeendemonstratedwhenprovidedbygeneral
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practitioners12 and by paramedics.13'14 Numerous
studieshavedemonstratedasuperiorityofprimary
angioplasty overTTinreducingmortality1I butit
isunlikelytobecomewidelyavailableinthenear
future so TT continues to be the mainstay of
reperfusion therapy.
Inorderto assess theefficiency ofdelivery ofTT
in aregion where mobile coronary care is widely
availableweconductedaprospectivestudyofthe
timelinessofadministration, appropriateness and
effectivenessofthistherapythroughoutNorthern
Ireland over a six-month period.
PATIENTS AND METHODS
All fifteen hospitals providing acute coronary
careinNorthernIreland(population 1.69million)
participated in the study and data were collected
over six months from 1/04/01 to 30/09/01.
Documentation was carried out by designated
members ofmedical staffor senior nursing staff
with the assistance ofaudit department staff. All
patients admitted to hospital who received TT or
whohadafinaldiagnosisofmyocardialinfarction
were included. Information relating to previous
history, risk factors, indications and
contraindicationsforTT,delaytimesforprovision
of coronary care and TT, sites where TT was
administered, diagnostictests andmortalityrates
was collected. A copy ofthe electrocardiograph
(ECG) relevant to the decision for TT (usually
the admission ECG) was retained to allow the
accuracy ofthe diagnosis and appropriateness of
the clinical decision to be checked by an
independentassessor(C.W.)inconsultation with
the patient's consultant physician. The final
diagnosis of myocardial infarction was at the
discretion of the patient's consultant physician
and depended on ECG changes and the results of
cardiacenzymesand/ortroponinlevelsasusedin
the local hospitals. The variable use of troponin
levels throughout the hospitals led to a
considerablevariationinthresholdsfordiagnosis
of non- ST elevation infarction.
Eleven of the fifteen hospitals operated mobile
coronary care units of various types; ten were
staffedby adoctor, nurse and driver and one was
nurse led. The nurse led unit did not routinely
providepre-hospital TT. Allpatients inNorthern
Irelandhad access to a mobile coronary care unit
at the request of themselves, their general
practitioner or emergency ambulance personnel.
Patients were admitted via mobile coronary care
units,orviaaccidentandemergencydepartments,
or directly to hospital at the request of a general
TABLE I
Sex, age and medical history ofpatients with confirmed myocardial infarction whether or not
thrombolytic therapy (TT) was administered.
TTpatients
(494)
Non TT
patients
(1144)
Gender
Mean age (years)
Medical history
Male
Female
Male
Female
Myocardial infarction
Angina
Hypertension
Diabetes
Cigarette smoking (current)
Cigarette smoking (ex)
Family history of IHD
None of the above
The Ulster Medical Society, 2004.
357(72%)
137(28%)
62
72
111(22%)
123(25%)
177(36%)
61(12%)
180(36%)
113(23%)
161(33%)
44(9%)
652(57%)
492(43%)
69
75
377(33%)
442(39%)
447(39%)
210(18%)
255(22%)
260(23%)
273(24%)
104(9%)
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practitioner. The timeliness of administration of
TTwasrelatedtothevarious methods ofdelivery
of care and performance was measured against
targetsforcall-to-needleanddoor-to-needletimes
as recommended by the National Service
Framework for England and Wales (NSF).16
Statistics
Weconsideredthatstatisticalanalysis ofourdata
wouldnotbeappropriatebecausepatientsselected
or not selected for TT had quite different
prognostic indicators and severity of presenting
symptoms greatly influenced their selection for
the various routes of admission. Comparison of
the outcomes of these groups of patients would
therefore be inappropriate.
RESULTS
Over a six-month period 1638 patients with a
final diagnosis of acute myocardial infarction
were admitted to acute hospitals in Northern
Ireland. Theage, sexandpreviousmedicalhistory
of these patients, whether or not they received
TT, are shown inTable I. ThosewhoreceivedTT
were more likely to be younger, male, current
smokers, withafamily historyofischaemic heart
disease, and with less previous cardiovascular
disease.
There was significant ST segment elevation
consistent with acute myocardial infarction
withoutleftbundlebranchblockonthepresenting
ECG in 775 (47%) patients and 77 (5%) had left
bundle branch block. Sixty-nine of the patients
with left bundle branch block, seven with
TABLE II
Clinical contra-indications to TTamong 1638
patients with myocardial infarction.
Clinical Frequency
Contraindications
Late presentation 125(7.6%)
Potential bleeding risk 56(3.4%)
On anti-coagulant 34(2.1%)
Recent CVA/TIA 31(1.9%)
Age 27(1.6%)
Uncontrolled hypertension 7(0.4%)
Primary Angioplasty 2(0.1%)
Other 30(1.8%)
ventricular pacing rhythm and one with broad
complex tachycardia did not receive TT due to
the well-recognised diagnostic difficulty in the
presence of left bundle branch block'7 although
this ECG abnormality is not a contra-indication
to TT when there is strong clinical suspicion of
myocardialinfarction. Anadditional 191 patients
had at least one clinical contra-indication to TT
(TableII).Therefore584patientswereconsidered
eligible for and 494 (85%) received TT. Three
patientsrefusedTTand87 didnotreceiveTTdue
to difficulties with ECG interpretation.
An additional 18 patients received TT but were
later shown to have no evidence of myocardial
infarction. Elevenofthesepatientshadacceptable
criteria for the diagnosis of acute myocardial
infarction on the presenting ECG, eight with ST
segment elevation and three with left bundle
branch block. Seven patients received TT
inappropriately due to incorrect ECG
interpretationbutnountowardeffectsoftreatment
were noted.
ThefrequencyofTTforpatientswithmyocardial
infarction variedfrom 18% to 55% among the 15
hospitals mainly due to local differences in the
criteria used for final diagnosis of myocardial
infarctioninrelationto serumenzymeortroponin
levels in patients with chest pain without ST
segmentelevationonECG.Thiscausedvariability
of inclusion of patients with non-ST elevation
infarction who were ineligible for TT.
Ofthe 512 patients who had TT 282 (55%) were
treatedinhospitalcoronarycareunits, 130(25%)
were treated pre-hospital by mobile coronary
care units, 97 (19%) were treated in accident and
emergency departments, two were treated in
generalmedicalwardsandonepatientwastreated
by his general practitioner.
Timeliness ofTT
Of478patients whosetimeofonsetofsymptoms
was recorded the median delay from symptom
onset to initiation of TT was 175 minutes. The
median time from the patients first request for
medical assistance to onset of thrombolytic
therapy i.e. call to needle time, was 87 (7-1110)
minutes and call to needle time of s 60 minutes
was achieved in 152patients (32%). The shortest
median call to needle time was seen in patients
treated by mobile coronary care units when call
to needle time of < 60 minutes was achieved in
55% compared with 47% in accident and
C The Ulster Medical Society, 2004.
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Fig 1. Cumulative distribution of call-to-needle times
(times were indeterminate for 40 patients).
emergency departments and 17% in hospital
coronary care units (Figure 1). Of 123 patients
who received TT pre-hospital and had reliably
documented times the median delay from arrival
ofthemobileunit toinitiationofTT was 20mins.
Among 62patients who were attended by mobile
units but were transferred to hospital before TT
was administered the median call to needle time
was extended by 58 minutes.
Of 394 patients who activated out-of-hospital
medical attention by either ageneral practitioner
or emergency ambulance or mobile coronary
care unit, the median call-to-needle times were
60 minutes for those treated pre-hospital, 100
minutes for those treated in accident and
emergencydepartments and 126minutesforthose
treated inhospital coronary care units (Figure 2).
TheNSFtargetcall-to-needletimeof 60minutes
was achieved in only 20% and 7% of patients
treated in accident and emergency departments
100.
90 TT pre hospital (n=121)
a TT in A&E dept (n=40)
80- * TT in CCU (n=194)
70
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Fig 2. Cumulative distribution of call-to-needle times
forpatients whoinitially activatedout-of-hospital
medical attention (times were indeterminate for
38 patients)
andin coronary careunits respectively compared
with 55% of those treated pre-hospital.
For patients treated in hospital the median time
from arrival at hospital to the onset of TT, i.e.
door-to-needle time was 46 (0-1065) minutes.
Patients treated in accident and emergency
departments had the shortest median door-to-
needle time, especially when treated by accident
andemergencystaffratherthanwaitingforcardiac
unit staff(Figure 3). Door to needle time of < 30
minutes was achieved in 65% ofpatients treated
by accident and emergency staff compared with
Fig 3. Cumulative distribution of door-to-needle times
forpatients whoseTT was giveninhospital(times
were indeterminate for 7 patients)
only 32% when treated by cardiac unit staff in
accident and emergency departments and 29%
when treated in coronary care units.
Among patients whose call-to-needle time was
more than 60 minutes important reasons noted
for the delay were slow response by the general
practitioner in 31(6%) or request by the general
practitioner for the patient to attend the health
centre in 13(3%), distance from hospital in
24(5%), non-diagnostic initialECGnecessitating
repeat ECGs in 38(7%), initial clinical condition
requiring stabilization before administering TT
in 31(6%), uncertainty ofthe diagnosis requiring
investigations such as echocardiography before
administeringTTin8(2%), andconsultation with
aseniormemberofstaffin 19(4%). In31(6%) the
delay time could notbe defined and in40(8%) no
particular reason was identified.
Mortality Rates
Of the 1638 patients with a final diagnosis of
acute myocardial infarction 165(10%) died in
hospital and 204(12%) had died by six weeks
C The Ulster Medical Society, 2004.
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afterinfarction. Amongpatients withSTsegment
elevation on their presenting ECG who received
TT the in-hospital and six week mortality rates
were 10% (49/494) and 11% (56/494)
respectively, compared with 18%(60/331) and
20% (67/331) respectively for those who did not
receive TT. However the higher frequency of
adverse factors among those who were not given
TT may have contributed to this difference in
TABLE III
Mortality rates according to the site of
administration ofTTforpatients with
confirmed myocardial infarction.
Site ofTT Hospitl 6-week
mortality mortality
Pre-hospital (123) 10(8.1%) 12(9.8%)
A&E dept (92) 8(8.7%) 10(10.9%)
Coronary care (277) 31(11.2%) 34(12.3%)
Other (2) 0 0
outcome making statistical comparison
inappropriate. When TT was given pre-hospital
or in accident and emergency departments
mortality rates tended to be lower than when it
was given in coronary care units (Table III).
DISCUSSION
With the advent of TT for acute myocardial
infarction it appeared that, within the UK,
Northern Irelandwas in auniquely advantageous
situationtoachievethemaximumbenefitbecause
of widespread availability of mobile coronary
care. This provided the means to deliver TT
promptly to the coronary patient in addition to
providing all other necessary acute treatment to
stabilisethepatient. Thetimedelayfromcoronary
occlusion, presumed to be onset ofsymptoms, to
TT determines the likelihood of successful
reperfusion but its largest component is patient
delay before summoning help8"19 which, in this
study, was about 90 mins. Unfortunately this
cannot easily be altered 1" but call-to-needle and
door-to-needle times should be amenable to
improvementbychangesinstrategy. Inthisstudy
pre-hospitalTT, whichaccountedforaquarterof
allTT, wasassociatedwith shortercall-to-needle
times compared with in-hospital administration.
Delaying administration of TT by transfer to
hospital extended delay to TT by about an hour.
Patients treated in accident and emergency
departmentsreceivedTTearlierthanthosetreated
in hospital coronary care units but call-to-needle
time 5 60 minutes as recommended by the NSF
was achieved in the majority of patients only
when TT was given pre-hospital. Similar
reductionsincall-to-needletimeshavepreviously
been achieved when TT was administered pre-
hospital by general practitioners,12 paramedics
with hospital based support,'3" 4 20 and mobile
coronary care units.21'22 Meta-analyses have
shown significant reduction in delay and lower
mortality rates associated with pre-hospital
compared with in-hospital TT.9 23 The National
AuditofMyocardialInfarctionProject(MINAP)
reported that, in its first six months, which was
roughly contemporary with this study, 20% of
eligiblepatientsweretreatedwithinsixtyminutes
ofcalling for help.24 This compares with 32% of
patients in this study but only approximately 2%
in MINAP received pre-hospital TT. However
MINAP showed improvement to 47% achieving
target call-to-needle times by the year 2003.
Among patients treated in hospital the NSF
recommended door-to-needle time was achieved
in only a third of patients compared to 43% of
eligiblepatients inthefirstsixmonthsofMINAP
and this figure improved to 78% by 2003.24
However, in this study, when treatment was
administered by accident and emergency staff
the target door-to-needle time was achieved in
65% compared with only 32% ifintervention by
cardiacunitstaffwasrequested. Previousreports
have similarly indicated shorterin-hospitaldelay
whenTTwasprovidedinaccidentandemergency
departments 18, 25,26 and the delay was doubledby
theneedtoconsultaseniorcolleague.18However,
whilstunnecessary delay should be avoided, it is
oftenappropriate to obtain a more senioropinion
to ensure accurate selection for this relatively
high risk treatment. In addition, the importance
of other components of care in acute coronary
syndromes, other than TT, must not be
underestimated and it is essential that all staff
working in this field are appropriately trained.
The availability of mainly doctor-led mobile
coronary care in Northern Ireland probably
contributed greatly to the relatively low overall
mortality rate in this study. A task force of the
European Society of Cardiology recommended
that personnel providing pre-hospital TT should
be trained in all aspects of the diagnosis and
treatment of myocardial infarction.27
C) The Ulster Medical Society, 2004.
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Abouthalfofallpatients withafinaldiagnosis of
acutemyocardialinfarctionhadneitherdiagnostic
ST segment elevation nor left bundle branch
block on the presenting ECG which is similar to
a previous report28 and a further 12% had
contraindications to TT but it was disappointing
tofindthat 15% ofpatientseligibleforTTdidnot
receive it. This compares with previous studies,
which have reported 14-33% incidence of
administrationfailure 29-32whileMINAPrecently
reported only 6% failure rate.24 It has been
demonstratedthatincreasingtheaccuracyofECG
analysis by input from consultant staffby means
of a fax facility improved decision-making with
regard to TT and provided support for junior
doctors when the interpretation of the ECG was
in doubt.33 Several mobile coronary care units in
NorthernIrelandnowhavethefacilitytotransmit
electrocardiograms by modem/fax technology to
the central CCU or to a consultant's home for a
second opinion.
The recent introduction of serum troponin
estimations has led to a dramatic increase in the
frequency of diagnosis of myocardial
infarction 34'35 but the number treated by TT has
remained relatively unchanged as the increase
has been due to inclusion of more patients with
non-ST elevation infarction who are not
considered suitable for TT resulting in reduction
of TT rates for all patients with myocardial
infarction from 40% to 26%.35This phenomenon
explains the apparently low proportion (30%) of
myocardial infarction patients who received TT
in this study.
It is clear that there are significant shortfalls in
achieving NSF targets in Northern Ireland as
previously observed in an audit of English
hospitals,36 although MINAP reports marked
improvements inperformanceoverrecentyears.24
Reasons for delay in this study, which are not
realistically amenable to improvement, were
identified in at least 30% of patients receiving
TT.Thetargetcall-to-needletimeof <60minutes
is therefore unrealistic for many of our patients
but the most likely method of reducing out-of-
hospital delay appears to be increased utilization
ofpre-hospitalTTdeliveredbyadequatelystaffed
mobile units while in-hospital delay could be
significantlyreducedbyimprovingcollaboration
between accident and emergency departments
andcoronary care units. Our findings support the
NSF,'6 the NICE guidelines 37an the European
Society of Cardiology task force,27 all of which
have suggested that it is appropriate to provide
pre-hospital TT where local call-to-door times
are likely to be more than 30 minutes, as pertains
throughoutthepredominantlyruralpopulationof
NorthernIreland, andthatTTshouldbeavailable
in accident and emergency departments.
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